Clinical Trial Update: Dysport® Adult Lower Limb Spasticity Follow-on Study [Phase 3]

View source ↗

Summary

Phase 3 follow-on study of Dysport for adult lower limb spasticity after stroke or traumatic brain injury has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity
• Spasticity After Traumatic Brain Injury

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Post-stroke Spasticity, Spasticity Post-Traumatic Brain Injury | Phase 3 | Status: COMPLETED | Results posted: 2017-11-09